Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brinzolamide/brimonidine fixed-combination versus concomitant brinzolamide plus brimonidine in open-angle glaucoma or ocular hypertension
2010-024513-31Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of brinzolamide and brimonidine in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Mean diurnal intraocular pressure change from baseline at Month 3. Started Apr 2011; status: completed.
02
Drugs
brinzolamidebrimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2010-024513-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024513-31.